Paris, France

Françoise Perron-Sierra

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1995-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Françoise Perron-Sierra

Introduction

Françoise Perron-Sierra is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of four patents to his name, Perron-Sierra has focused on developing compounds that have the potential to treat various medical conditions.

Latest Patents

Among his latest patents is a process for the preparation of amino acid derivatives and pharmaceutical compositions containing them. These compounds are designed to be useful in treating conditions that require a pro-apoptotic agent. Another significant patent involves thienopyrimidine derivatives, which are also aimed at creating medicinal products that can address pathologies involving a deficit in apoptosis, such as cancer and autoimmune diseases.

Career Highlights

Throughout his career, Françoise Perron-Sierra has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Les Laboratoires Servier and Vernalis Limited, where he contributed to research and development efforts. His work has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Perron-Sierra has collaborated with esteemed colleagues, including András Kotschy and Zoltán Szlávik. These partnerships have further enriched his research and innovation endeavors.

Conclusion

Françoise Perron-Sierra's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…